BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27618583)

  • 1. C/EBP-β Is Differentially Affected by PPARα Agonists Fenofibric Acid and GW7647, But Does Not Change Apolipoprotein A-I Production During ER-Stress and Inflammation.
    van der Krieken SE; Popeijus HE; Konings M; Dullens SP; Mensink RP; Plat J
    J Cell Biochem; 2017 Apr; 118(4):754-763. PubMed ID: 27618583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Link Between ER-Stress, PPAR-Alpha Activation, and BET Inhibition in Relation to Apolipoprotein A-I Transcription in HepG2 Cells.
    van der Krieken SE; Popeijus HE; Mensink RP; Plat J
    J Cell Biochem; 2017 Aug; 118(8):2161-2167. PubMed ID: 28012209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiated CaCo-2 cells as an in-vitro model to evaluate de-novo apolipoprotein A-I production in the small intestine.
    Dullens SP; Mensink RP; Mariman EC; Plat J
    Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):642-9. PubMed ID: 19445040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Chain Fatty Acids (Except Hexanoic Acid) Lower NF-kB Transactivation, Which Rescues Inflammation-Induced Decreased Apolipoprotein A-I Transcription in HepG2 Cells.
    Tayyeb JZ; Popeijus HE; Mensink RP; Konings MCJM; Mokhtar FBA; Plat J
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARγ Represses Apolipoprotein A-I Gene but Impedes TNFα-Mediated ApoA-I Downregulation in HepG2 Cells.
    Shavva VS; Mogilenko DA; Bogomolova AM; Nikitin AA; Dizhe EB; Efremov AM; Oleinikova GN; Perevozchikov AP; Orlov SV
    J Cell Biochem; 2016 Sep; 117(9):2010-22. PubMed ID: 26813964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C/EBP β Mediates Endoplasmic Reticulum Stress Regulated Inflammatory Response and Extracellular Matrix Degradation in LPS-Stimulated Human Periodontal Ligament Cells.
    Bai Y; Wei Y; Wu L; Wei J; Wang X; Bai Y
    Int J Mol Sci; 2016 Mar; 17(3):385. PubMed ID: 27011164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-α activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway.
    Nakaya K; Tohyama J; Naik SU; Tanigawa H; MacPhee C; Billheimer JT; Rader DJ
    Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1276-82. PubMed ID: 21441141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-Scale Screening of Natural Products Transactivating Peroxisome Proliferator-Activated Receptor α Identifies 9S-Hydroxy-10E,12Z,15Z-Octadecatrienoic Acid and Cymarin as Potential Compounds Capable of Increasing Apolipoprotein A-I Transcription in Human Liver Cells.
    van der Krieken SE; Popeijus HE; Bendik I; Böhlendorf B; Konings MCJM; Tayyeb J; Mensink RP; Plat J
    Lipids; 2018 Nov; 53(11-12):1021-1030. PubMed ID: 30706477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amoxicillin Modulates ApoA-I Transcription and Secretion, Predominantly via PPARα Transactivation Inhibition.
    Tayyeb JZ; Popeijus HE; Mensink RP; Konings MCJM; Mulders KHR; Plat J
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31783518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor α agonists.
    Patil R; Mohanty B; Liu B; Chandrashekaran IR; Headey SJ; Williams ML; Clements CS; Ilyichova O; Doak BC; Genissel P; Weaver RJ; Vuillard L; Halls ML; Porter CJH; Scanlon MJ
    J Biol Chem; 2019 Mar; 294(10):3720-3734. PubMed ID: 30598509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmitic acid aggravates inflammation of pancreatic acinar cells by enhancing unfolded protein response induced CCAAT-enhancer-binding protein β-CCAAT-enhancer-binding protein α activation.
    Wu J; Hu G; Lu Y; Zheng J; Chen J; Wang X; Zeng Y
    Int J Biochem Cell Biol; 2016 Oct; 79():181-193. PubMed ID: 27592456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the nuclear receptors HNF4 alpha, PPAR alpha, and LXRs in the TNF alpha-mediated inhibition of human apolipoprotein A-I gene expression in HepG2 cells.
    Mogilenko DA; Dizhe EB; Shavva VS; Lapikov IA; Orlov SV; Perevozchikov AP
    Biochemistry; 2009 Dec; 48(50):11950-60. PubMed ID: 19883121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
    Ge J; Miao JJ; Sun XY; Yu JY
    J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.
    Paukkeri EL; Leppänen T; Sareila O; Vuolteenaho K; Kankaanranta H; Moilanen E
    Br J Pharmacol; 2007 Dec; 152(7):1081-91. PubMed ID: 17891158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating PPARα prevents post-ischemic contractile dysfunction in hypertrophied neonatal hearts.
    Lam VH; Zhang L; Huqi A; Fukushima A; Tanner BA; Onay-Besikci A; Keung W; Kantor PF; Jaswal JS; Rebeyka IM; Lopaschuk GD
    Circ Res; 2015 Jun; 117(1):41-51. PubMed ID: 25977309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoplasmic reticulum stress-activated C/EBP homologous protein enhances nuclear factor-kappaB signals via repression of peroxisome proliferator-activated receptor gamma.
    Park SH; Choi HJ; Yang H; Do KH; Kim J; Lee DW; Moon Y
    J Biol Chem; 2010 Nov; 285(46):35330-9. PubMed ID: 20829347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARα agonist and metformin co-treatment ameliorates NASH in mice induced by a choline-deficient, amino acid-defined diet with 45% fat.
    Okishio S; Yamaguchi K; Ishiba H; Tochiki N; Yano K; Takahashi A; Kataoka S; Okuda K; Seko Y; Liu Y; Fujii H; Takahashi D; Ito Y; Kamon J; Umemura A; Moriguchi M; Yasui K; Okanoue T; Itoh Y
    Sci Rep; 2020 Nov; 10(1):19578. PubMed ID: 33177546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways.
    Ramanan S; Kooshki M; Zhao W; Hsu FC; Robbins ME
    Free Radic Biol Med; 2008 Dec; 45(12):1695-704. PubMed ID: 18852043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor alpha agonists enhance cardiomyogenesis of mouse ES cells by utilization of a reactive oxygen species-dependent mechanism.
    Sharifpanah F; Wartenberg M; Hannig M; Piper HM; Sauer H
    Stem Cells; 2008 Jan; 26(1):64-71. PubMed ID: 17951219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.